SeaStar Medical Holding Corp

For the period ended Mar 31, 2025. Filed May 14, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 14, 2025

ICU$1.96+4.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	March 31,2025	December 31,2024
(unaudited)
ASSETS
Current assets
Cash	$5,296	$1,819
Accounts receivable, net	110	112
Inventory	44	—
Prepaid expenses	1,334	1,835
Total current assets	6,784	3,766
Other assets	813	892
Total assets	$7,597	$4,658
LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT)
Current liabilities
Accounts payable	$3,397	$3,046
Accrued expenses	3,255	3,188
Notes payable, net of deferred financing costs	363	574
Liability classified warrants	17	33
Total current liabilities	7,032	6,841
Total liabilities	7,032	6,841
Commitments and contingencies (Note 10)
Stockholders’ equity/(deficit)
Preferred stock - $0.0001 par value, 10,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024	—	—
Common stock - $0.0001 par value per share; 450,000,000 and 500,000,000 shares authorized at March 31, 2025 and December 31, 2024, respectively; 9,257,763 and 5,977,246 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	2	2
Additional paid-in capital	143,899	137,379
Accumulated deficit	(143,336)	(139,564)
Total stockholders’ equity/(deficit)	565	(2,183)
Total liabilities and stockholders’ equity/(deficit)	$7,597	$4,658

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.